Skip to main content

Table 5 Comparison of mean ± SD macronutrient intake at baseline and 12-weeks

From: Does a ketogenic diet have beneficial effects on quality of life, physical activity or biomarkers in patients with breast cancer: a randomized controlled clinical trial

Variable

KD

Mean ± SD

Control

Mean ± SD

MD (0.95 CI)

p-value

Energy (Kcal/day)

 Before

1743 ± 305

1789 ± 323

−45 (− 222,131)

0/60

 After

1245 ± 360

1600 ± 304

− 355 (− 577,-132)

0/003

p-value

0</001

0/001

  

Carbohydrate (gr)

 Before

235 ± 52

238 ± 54

−2.6 (−32,27)

0/85

 After

22 ± 11

208 ± 60

− 185 (− 210,-159

0</001a

p-value

0</001

0/03

  

Protein (gr)

 Before

73 ± 13

71 ± 22

1.5 (−8.9,11.9)

0/76

 After

61 ± 61

72 ± 71

−10 (−21.9,1.5)

0.41a

p-value

0/02

0/003

  

Fat (gr)

 Before

56 ± 11

61 ± 15

−4.6(−12.2,3)

0/23

 After

101 ± 32

53 ± 11

48 (31,65)

0</001a

p-value

0</001

0/007

  
  1. Student t-test was used to compare the continuous variables between the two groups. Paired sample t-test was used to compare the continuous variables within the groups
  2. MD Mean difference
  3. CI Confidence interval
  4. aAncova: Adjusted for baseline value and energy